![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD
One of the obstacles to chronic GVHD research is the lack of standardized response criteria. The National Institute of Health (NIH) has recommended response criteria at a Consensus Conference. These need to be...
-
Article
Erratum: Toxic absorption of pimecrolimus in a patient with severe acute graft-versus-host disease
Correction to: Bone Marrow Transplantation (2005) 36, 919–920. doi:10.1038/sj.bmt1705146 My attention has been drawn to the fact that the authors of this letter believed that the patient's cutaneous GvHD was t...
-
Article
Toxic absorption of pimecrolimus in a patient with severe acute graft-versus-host disease
-
Article
A case of retroperitoneal fibrosis in a patient following HSCT
-
Article
High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases
T-cell depletion of the marrow graft using counterflow centrifugal elutriation reduces the risk of graft-versus-host disease (GVHD). However, because of high rates of graft failure and relapse, elutriation alo...